Home › Life Technologies Announces Regulatory Approval of Its 3500 Dx Series Genetic Analyzers in Canada
 

Keywords :   


Life Technologies Announces Regulatory Approval of Its 3500 Dx Series Genetic Analyzers in Canada

2013-05-20 06:00:00| Industrial Newsroom - All News for Today

CARLSBAD, Calif. -- Life Technologies Corporation (NASDAQ:LIFE) today announced that its Applied Biosystems&trade; 3500 Dx /3500 xL Dx Genetic Analyzers CS2 have been approved by Health Canada for diagnostic use. The development marks a major extension of Life Technologies' capabilities to serve the clinical end market in North America with Sanger-based solutions.<br /> <br /> The Applied Biosystems&trade; 3500 Dx Series Genetic Analyzers deliver high quality performance, higher throughput and ...This story is related to the following:Test and Measuring InstrumentsSearch for suppliers of: Diagnostic Instruments |

Tags: life canada series technologies

Category:Industrial Goods and Services

Latest from this category

All news
19.11POWTEX2024 The 25th International Powder Technology Exhibition Tokyo
Industrial Goods and Services »
27.11 ( #1670 )
27.1117 AIR AGS 83M-S
27.11 XYZ 3
27.11XVSecret1
27.11NFT ADVANCE 3-370!
27.11 101
27.11
27.11 DESCENTE L
More »